INTRODUCTION
The overall data showed a cure rate (those achieving euthyroidism or hypothyroidism) for Graves' Disease of 100% by 12 months 45 patients identified having radioiodine treatment during time period analysed, two of whom were lost to follow up and therefore excluded -The indications of Radioiodine (131I) in benign thyroid disease include therapy for hyperthyroidism -Graves' disease, Toxic goitre (solitary toxic adenomas or multinodular goitre) and euthyroid goitre
All patients had active eye disease excluded -There was appropriate adherence to national guidance* at both sites and lower doses were used with similar efficacy. Hence further comparisons with other centres using dosage calculations may be a useful guide in reflective practice -Thyroid eye clinics for exclusion and stabilisation of eye disease prior to radioiodine treatment should be utilised 
